CPC technology class · A61
A61F - Filters Implantable INTO Blood Vessels
Filters implantable into blood vessels; prostheses; devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents; orthopaedic, nursing or contraceptive devices; fomentation; treatment or protection of eyes or ears; bandages, dressings or absorbent pads; firs. 50,959 US utility patents granted 2015–2025, with the leading assignees and year-by-year filing trajectory.
- 50,959
- US patents granted
- A61
- Parent CPC class
- 20
- Active assignees
- +15%
- 5-yr velocity
The verdict
Filters Implantable INTO Blood Vessels ranks #33 of 670 CPC technology areas - 50,959 US patents granted since 2015, with filing up 15% over five years.
- #33
- of 670 CPC technology areas
- 50,959
- US patents granted, 2015–2025
- The Procter & Gamble
- leading assignee (1,426)
- +15%
- filing velocity, last 5 yrs
CPC subclass A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS - covers 50,959 US utility patents granted between 2015 and 2025 according to USPTO PatentsView records, within the broader CPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). See our CPC classification guide for how the system works.
The competitive landscape in A61F is shaped by 20 distinct companies actively filing in this space. The Procter & Gamble Company leads with 1,426 patents, followed by Boston Scientific Scimed, Inc. at 1,101 grants and Edwards Lifesciences Corporation at 1,101.
Filing activity in A61F is up 15% over the past five years versus 2015-2019, a relatively steady filing pace. All counts come directly from USPTO PatentsView and reflect US granted utility patents only.
Is A61F innovation accelerating?
US utility-patent grants per year in A61F, 2015–2025 - recent five years are up 15% versus 2015–2019.
Who leads A61F?
The 12 most active assignees in FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS - wider bars mean more grants
- The Procter & Gamble
The Procter & Gamble Company
1,426 patents
- Boston Scientific Sci…
Boston Scientific Scimed, Inc.
1,101 patents
- Edwards Lifesciences
EDWARDS LIFESCIENCES CORPORATION
1,101 patents
- Depuy Synthes Products
DePuy Synthes Products, Inc.
851 patents
- Globus Medical
Globus Medical, Inc.
752 patents
- Cook Medical
COOK MEDICAL TECHNOLOGIES LLC
700 patents
- Smith & Nephew 541
SMITH & NEPHEW, INC.
541 patents
- Covidien 528
Covidien LP
528 patents
- Alcon 489
ALCON INC.
489 patents
- Kimberly-clark Worldw… 427
Kimberly-Clark Worldwide, Inc.
427 patents
- W L Gore & Associates 420
W.L. Gore & Associates GmbH
420 patents
- Kci Licensing 417
KCI Licensing, Inc.
417 patents
What this shows The Procter & Gamble is the most active filer in A61F, holding 1,426 of the 50,959 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in A61F |
|---|---|---|
| #1 | The Procter & Gamble Company | 1,426 |
| #2 | Boston Scientific Scimed, Inc. | 1,101 |
| #3 | Edwards Lifesciences Corporation | 1,101 |
| #4 | Depuy Synthes Products, Inc. | 851 |
| #5 | Globus Medical, Inc. | 752 |
| #6 | COOK Medical Technologies Llc | 700 |
| #7 | Smith & Nephew, Inc. | 541 |
| #8 | Covidien Lp | 528 |
| #9 | Alcon Inc. | 489 |
| #10 | Kimberly-clark Worldwide, Inc. | 427 |
| #11 | W.l. Gore & Associates Gmbh | 420 |
| #12 | KCI Licensing, Inc. | 417 |
| #13 | Warsaw Orthopedic, Inc. | 415 |
| #14 | Howmedica Osteonics Corp. | 392 |
| #15 | Abbott Cardiovascular Systems, Inc. | 385 |
| #16 | Medtronic Vascular, Inc. | 383 |
| #17 | Coloplast A/s | 378 |
| #18 | Unicharm Corporation | 369 |
| #19 | Zimmer, Inc. | 363 |
| #20 | Medtronic, Inc. | 318 |
About This Class
CPC subclass A61F belongs to class A61.
50,959 patents were granted in this class between 2015 and 2025.
20 companies actively patent in this space.
Classification System
Cooperative Patent Classification (CPC) is a hierarchical patent classification system used by the USPTO and EPO.
Footprint here vs. claim strategy
Each dot is a leading A61F assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.
Top 14 A61F assignees by class footprint. Bubble size = patents in A61F. Source: USPTO PatentsView (claim depth is company-wide across all classes).
Frequently Asked Questions
What is CPC class A61F?
How many patents have been filed in A61F?
Which company holds the most patents in A61F?
How is patent data for A61F collected?
What is the difference between CPC class and subclass?
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.